Your browser doesn't support javascript.
loading
A Highly Potent SARS-CoV-2 Blocking Lectin Protein.
Ahan, Recep E; Hanifehnezhad, Alireza; Kehribar, Ebru S; Oguzoglu, Tuba C; Földes, Katalin; Özçelik, Cemile E; Filazi, Nazlican; Öztop, Sidika; Palaz, Fahreddin; Önder, Sevgen; Bozkurt, Eray U; Ergünay, Koray; Özkul, Aykut; Seker, Urartu Özgür Safak.
Afiliación
  • Ahan RE; UNAM-Institute of Materials Science and Nanotechnology, Bilkent University, Ankara 06800, Turkey.
  • Hanifehnezhad A; Faculty of Veterinary Medicine, Department of Virology, Ankara University, Ankara 06110, Turkey.
  • Kehribar ES; UNAM-Institute of Materials Science and Nanotechnology, Bilkent University, Ankara 06800, Turkey.
  • Oguzoglu TC; Faculty of Veterinary Medicine, Department of Virology, Ankara University, Ankara 06110, Turkey.
  • Földes K; Faculty of Veterinary Medicine, Department of Virology, Ankara University, Ankara 06110, Turkey.
  • Özçelik CE; UNAM-Institute of Materials Science and Nanotechnology, Bilkent University, Ankara 06800, Turkey.
  • Filazi N; Faculty of Veterinary Medicine, Department of Virology, Ankara University, Ankara 06110, Turkey.
  • Öztop S; Adana Dr. Turgut Noyan Medical and Research Center, Department of Immunology, Baskent University, Adana 01250, Turkey.
  • Palaz F; Faculty of Medicine, Hacettepe University, Ankara 06230, Turkey.
  • Önder S; Faculty of Medicine, Department of Medical Pathology, Hacettepe University, Ankara 06230, Turkey.
  • Bozkurt EU; UNAM-Institute of Materials Science and Nanotechnology, Bilkent University, Ankara 06800, Turkey.
  • Ergünay K; Faculty of Medicine, Department of Medical Microbiology, Virology Unit, Hacettepe University, Ankara 06230, Turkey.
  • Özkul A; Faculty of Veterinary Medicine, Department of Virology, Ankara University, Ankara 06110, Turkey.
  • Seker UÖS; Biotechnology Institute, Ankara University, Ankara 06135, Turkey.
ACS Infect Dis ; 8(7): 1253-1264, 2022 07 08.
Article en En | MEDLINE | ID: mdl-35426678

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: SARS-CoV-2 / COVID-19 / Tratamiento Farmacológico de COVID-19 Límite: Animals / Humans Idioma: En Revista: ACS Infect Dis Año: 2022 Tipo del documento: Article País de afiliación: Turquía

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: SARS-CoV-2 / COVID-19 / Tratamiento Farmacológico de COVID-19 Límite: Animals / Humans Idioma: En Revista: ACS Infect Dis Año: 2022 Tipo del documento: Article País de afiliación: Turquía